Filing Details
- Accession Number:
- 0001127602-13-026579
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-09-04 16:52:01
- Reporting Period:
- 2013-09-03
- Filing Date:
- 2013-09-04
- Accepted Time:
- 2013-09-04 16:52:01
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875045 | Biogen Idec Inc. | BIIB | Biological Products, (No Disgnostic Substances) (2836) | 330112644 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1202102 | A George Scangos | Biogen Idec Inc. 133 Boston Post Road Weston MA 02493 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2013-09-03 | 227 | $213.80 | 45,534 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-09-03 | 600 | $214.74 | 44,934 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-09-03 | 300 | $216.26 | 44,634 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-09-03 | 912 | $213.30 | 43,722 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-09-03 | 200 | $216.31 | 43,522 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 5,378 | Indirect | by Trust |
| Common Stock | 5,378 | Indirect | by Trust |
Footnotes
- Sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.
- Full information regarding the number of shares sold at each separate price will be provided upon request by the SEC staff, the issuer, or a security holder of the issuer.
- This represents the weighted average price for shares sold at a range between $213.44 (low) and $213.91 (high).
- This represents the weighted average price for shares sold at a range between $214.51 (low) and $215.00 (high).
- This represents the weighted average price for shares sold at a range between $216.14 (low) and $216.31 (high).
- This represents the weighted average price for shares sold at a range between $213.12 (low) and $213.84 (high).
Billionaire Hedge Funds
